Skip to main content

Advertisement

Log in

Surgical outcomes and predictors of glucose metabolism alterations for growth hormone-secreting pituitary adenomas: a hospital-based study of 151 cases

  • Endocrine Surgery
  • Published:
Endocrine Aims and scope Submit manuscript

Abstract

Purpose

The surgical outcome on glucose metabolism in acromegaly patients is not fully understood. We aimed to investigate the impact of surgery on glucose metabolism and identify key factors that influence alterations of glucose metabolic status in acromegaly patients.

Methods

Oral glucose tolerance test was performed in 151 newly diagnosed acromegaly patients before and 3–12 months after surgery. Insulin resistance and insulin secretion was assessed. Patients were grouped as cured, discordant, and having active disease according to postoperative growth hormone (GH) and insulin-like growth factor-1 (IGF-1) levels. Receiver-operating characteristic curves were generated to determine the optimal cut-off points to predict the impact of surgery on glucose metabolism.

Results

At baseline, 32.5%, 41.7%, and 25.8% patients were categorized as having normal glucose tolerance (NGT), impaired glucose tolerance (IGT), and diabetes mellitus (DM), respectively. After surgery, improved glucose tolerance was observed in 87.3% patients with IGT and 66.7% patients with DM. Deterioration was observed in 14.3% patients with NGT. Glucose tolerance improved in patients with lower preoperative FBG, 2 h-BG, and HbA1c and higher HOMA-β and IGI/IR. The proportion of NGT was significantly increased in surgically cured patients (28.3% vs. 79.2%, P < 0.001) and those with normal GH but elevated IGF-1 levels (25.6% vs. 79.5%, P < 0.001), but not in patients with active disease (42.9% vs. 57.1%, P = 0.131). Baseline FBG < 6.35 mmol/l predicted improved glucose metabolism after surgery.

Conclusions

Glucose metabolic status improved in patients with preserved β-cell function. Preoperative FBG was an independent predictor for improved glucose tolerance status after surgery.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2

Similar content being viewed by others

References

  1. J.J. Puder, S. Nilavar, K.D. Post, P.U. Freda, Relationship between disease-related morbidity and biochemical markers of activity in patients with acromegaly. J. Clin. Endocrinol. Metab. 90(4), 1972–1978 (2005)

    Article  CAS  Google Scholar 

  2. A. Colao, D. Ferone, P. Marzullo, G. Lombardi, Systemic complications of acromegaly: epidemiology, pathogenesis, and management. Endocr. Rev. 25(1), 102 (2004)

    Article  CAS  Google Scholar 

  3. D.R. Clemmons, Roles of insulin-like growth factor-I and growth hormone in mediating insulin resistance in acromegaly. Pituitary 5(3), 181–183 (2002)

    Article  CAS  Google Scholar 

  4. L. Katznelson, E.R. Laws Jr., S. Melmed, M.E. Molitch, M.H. Murad, A. Utz, J.A. Wass, S. Endocrine, Acromegaly: an endocrine society clinical practice guideline. J. Clin. Endocrinol. Metab. 99(11), 3933–3951 (2014)

    Article  CAS  Google Scholar 

  5. A. Goldhirsch, J.H. Glick, R.D. Gelber, H.J. Senn, A consensus on criteria for cure of acromegaly. J. Clin. Endocrinol. Metab. 95(7), 3141–3148 (2010)

    Article  Google Scholar 

  6. M.L. Jaffrain-Rea, G. Minniti, C. Moroni, V. Esposito, E. Ferretti, A. Santoro, T. Infusino, G. Tamburrano, G. Cantore, R. Cassone, Impact of successful transsphenoidal surgery on cardiovascular risk factors in acromegaly. Eur. J. Endocrinol. 148(2), 193 (2003)

    Article  CAS  Google Scholar 

  7. Y. Kinoshita, H. Fujii, A. Takeshita, M. Taguchi, M. Miyakawa, K. Oyama, S. Yamada, Y. Takeuchi, Impaired glucose metabolism in Japanese patients with acromegaly is restored after successful pituitary surgery if pancreatic {beta}-cell function is preserved. Eur. J. Endocrinol. 164(4), 467–473 (2011)

    Article  CAS  Google Scholar 

  8. M. Tzanela, D.A. Vassiliadi, N. Gavalas, A. Szabo, E. Margelou, A. Valatsou, C. Vassilopoulos, Glucose homeostasis in patients with acromegaly treated with surgery or somatostatin analogues. Clin. Endocrinol. 75(1), 96 (2011)

    Article  CAS  Google Scholar 

  9. A.D. Association, Diagnosis and classification of diabetes mellitus. Diabetes Care 34(Suppl 1), S62–S69 (2011)

    Article  Google Scholar 

  10. A.V. Dreval, I.V. Trigolosova, I.V. Misnikova, Y.A. Kovalyova, R.S. Tishenina, I.S. Barsukov, A.V. Vinogradova, B.H.R. Wolffenbuttel, Prevalence of diabetes mellitus in patients with acromegaly. Endocr. Connect. 3(2), 93–98 (2014)

    Article  CAS  Google Scholar 

  11. J. Dal, U. Feldt-Rasmussen, M. Andersen, L.O. Kristensen, P. Laurberg, L. Pedersen, O.M. Dekkers, H.T. Sorensen, J.O. Jorgensen, Acromegaly incidence, prevalence, complications and long-term prognosis: a nationwide cohort study. Eur. J. Endocrinol. 175(3), 181–190 (2016)

    Article  CAS  Google Scholar 

  12. W. Yang, J. Lu, J. Weng, W. Jia, L. Ji, J. Xiao, Z. Shan, J. Liu, H. Tian, Q. Ji, Prevalence of diabetes among men and women in China. New Engl. J. Med. 362(25), 2425 (2010)

    Article  Google Scholar 

  13. O. Alexopoulou, M. Bex, P. Kamenicky, A.B. Mvoula, P. Chanson, D. Maiter, Prevalence and risk factors of impaired glucose tolerance and diabetes mellitus at diagnosis of acromegaly: a study in 148 patients. Pituitary 17(1), 81–89 (2014)

    Article  CAS  Google Scholar 

  14. S. Fieffe, I. Morange, P. Petrossians, P. Chanson, V. Rohmer, C. Cortet, F. Borson-Chazot, T. Brue, B. Delemer, F.A. Registry, Diabetes in acromegaly, prevalence, risk factors, and evolution: data from the French acromegaly registry. Eur. J. Endocrinol. 164(6), 877 (2011)

    Article  CAS  Google Scholar 

  15. S. Kasayama, M. Otsuki, M. Takagi, H. Saito, S. Sumitani, H. Kouhara, M. Koga, Y. Saitoh, T. Ohnishi, N. Arita, Impaired beta-cell function in the presence of reduced insulin sensitivity determines glucose tolerance status in acromegalic patients. Clin. Endocrinol. 52(5), 549–555 (2000)

    Article  CAS  Google Scholar 

  16. R. Helseth, S.M. Carlsen, J. Bollerslev, J. Svartberg, M. Øksnes, S. Skeie, S.L. Fougner, Preoperative octreotide therapy and surgery in acromegaly: associations between glucose homeostasis and treatment response. Endocrine 51(2), 298–307 (2016)

    Article  CAS  Google Scholar 

  17. A. Colao, R. Attanasio, R. Pivonello, P. Cappabianca, L.M. Cavallo, G. Lasio, A. Lodrini, G. Lombardi, R. Cozzi, Partial surgical removal of growth hormone-secreting pituitary tumors enhances the response to somatostatin analogs in acromegaly. J. Clin. Endocrinol. Metab. 91(1), 85–92 (2006)

    Article  CAS  Google Scholar 

  18. A. Colao, R.S. Auriemma, M. Galdiero, P. Cappabianca, L.M. Cavallo, F. Esposito, L.F. Grasso, G. Lombardi, R. Pivonello, Impact of somatostatin analogs versus surgery on glucose metabolism in acromegaly: results of a 5-year observational, open, prospective study. J. Clin. Endocrinol. Metab. 94(2), 528–537 (2009)

    Article  CAS  Google Scholar 

  19. C.L. Ronchi, V. Varca, P. Beck-Peccoz, E. Orsi, F. Donadio, A. Baccarelli, C. Giavoli, E. Ferrante, A. Lania, A. Spada, Comparison between six-year therapy with long-acting somatostatin analogs and successful surgery in acromegaly: effects on cardiovascular risk factors. J. Clin. Endocrinol. Metab. 91(1), 121–128 (2006)

    Article  CAS  Google Scholar 

  20. N. Møller, O. Schmitz, J.O. Jøorgensen, J. Astrup, J.F. Bak, S.E. Christensen, K.G. Alberti, J. Weeke, Basal- and insulin-stimulated substrate metabolism in patients with active acromegaly before and after adenomectomy. J. Clin. Endocrinol. Metab. 74(5), 1012–1019 (1992)

    PubMed  Google Scholar 

  21. K. Mori, Y. Iwasaki, Y. Kawasaki-Ogita, S. Honjo, Y. Hamamoto, H. Tatsuoka, K. Fujimoto, H. Ikeda, Y. Wada, Y. Takahashi, Improvement of insulin resistance following transsphenoidal surgery in patients with acromegaly: correlation with serum IGF-I levels. J. Endocrinol. Invest. 36(10), 853–859 (2013)

    CAS  PubMed  Google Scholar 

  22. B. Gallwitz, C. Kazda, P. Kraus, C. Nicolay, G. Schernthaner, Contribution of insulin deficiency and insulin resistance to the development of type 2 diabetes: nature of early stage diabetes. Acta Diabetol. 50(1), 39–45 (2013)

    Article  CAS  Google Scholar 

  23. M. Stelmachowskabanaś, G. Zieliński, P. Zdunowski, J. Podgórski, W. Zgliczyński, The impact of transsphenoidal surgery on glucose homeostasis and insulin resistance in acromegaly. Neurol. Neurochir. Pol. 45(4), 328–334 (2011)

    Article  Google Scholar 

  24. A.L. Espinosa-De-Los-Monteros, B. González, G. Vargas, E. Sosa, M. Mercado, Clinical and biochemical characteristics of acromegalic patients with different abnormalities in glucose metabolism. Pituitary 14(3), 231–235 (2011)

    Article  CAS  Google Scholar 

  25. C. Jonas, D. Maiter, O. Alexopoulou, Evolution of glucose tolerance after treatment of acromegaly: a study in 57 patients. Horm. Metab. Res. 48(5), 299–305 (2016)

    Article  CAS  Google Scholar 

  26. B. Gonzalez, G. Vargas, A.L.E. de Los Monteros, V. Mendoza, M. Mercado, Persistence of diabetes and hypertension after multimodal treatment of acromegaly. J. Clin. Endocrinol. Metab. 103(6), 2369–2375 (2018)

    Article  Google Scholar 

Download references

Acknowledgements

This work was supported by the National Natural Science Foundation of China (Grant numbers 81602191, 81702467), the Shanghai Municipal Commission of Health and Family Planning (Grant number XYQ201640058), and the Shanghai Sailing Program (Grant number 17YF1401500).

Funding

This study was funded by the National Natural Science Foundation of China (Grant numbers 81602191, 81702467), the Shanghai Municipal Commission of Health and Family Planning (Grant number XYQ201640058), and the Shanghai Sailing Program (Grant number 17YF1401500).

Author information

Authors and Affiliations

Authors

Corresponding authors

Correspondence to Ming Shen or Yongfei Wang.

Ethics declarations

Conflict of interest

The authors declare that they have no conflict of interest.

Ethical approval

All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.

Informed consent

Informed consent was obtained from all individual participants included in the study.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

He, W., Yan, L., Wang, M. et al. Surgical outcomes and predictors of glucose metabolism alterations for growth hormone-secreting pituitary adenomas: a hospital-based study of 151 cases. Endocrine 63, 27–35 (2019). https://doi.org/10.1007/s12020-018-1745-7

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12020-018-1745-7

Keywords

Navigation